This is a phase 1, open-label study to assess changes in mental well-being following MDMA administration within a therapeutic setting, in mental health providers who are in training to become MDMA assisted therapists. Secondary outcome measures will examine the effects on provider burnout, provider self-efficacy, mood, self-compassion, quality of life, and other psychological factors. Participants will work with a co-therapy pair as they engage in a preparatory session, one experimental session with MDMA, and an integration session the following day.
Protocol Amendment History
3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-31; most recent amendment 2026-03-26.
Status change: Not Yet Recruiting → Recruiting2025-12-18